Reappraisal of biosafety risks posed by PERVs in xenotransplantation

Reviews in Medical Virology

Volumn 18, Issue 1, 2008, Pages 53-65

  Louz, Derrick ^a   Bergmans, Hans E ^a   Loos, Birgit P ^a   Hoeben, Rob C ^b  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; GLYCOPROTEIN;

ACUTE GRAFT REJECTION; BIOARTIFICIAL LIVER; BIOSAFETY; CELLULAR IMMUNITY; CHRONIC GRAFT REJECTION; DATA ANALYSIS; GENOME ANALYSIS; HUMAN; HUMORAL IMMUNITY; HYPERACUTE GRAFT REJECTION; KIDNEY PERFUSION; LIVER PERFUSION; MURINE LEUKEMIA VIRUS; NONHUMAN; PANCREAS ISLET TRANSPLANTATION; PORCINE ENDOGENOS RETROVIRUS; PROVIRUS; RETROVIRUS; REVIEW; RISK ASSESSMENT; RISK FACTOR; SKIN GRAFT; SWINE; VIRAL GENETICS; VIRUS CELL INTERACTION; VIRUS GENOME; VIRUS REPLICATION; VIRUS TRANSMISSION; VIRUS VIRULENCE; XENOTRANSPLANTATION;

ANIMALS; DISEASE TRANSMISSION, VERTICAL; ENDOGENOUS RETROVIRUSES; HUMANS; PROVIRUSES; RETROVIRIDAE INFECTIONS; RISK FACTORS; SAFETY; SWINE; SWINE DISEASES; TRANSPLANTATION, HETEROLOGOUS;

EID: 38549110052     PISSN: 10529276     EISSN: None     Source Type: Journal    
DOI: 10.1002/rmv.559     Document Type: Review

References (110)

1. Dorling A, Riesbeck K, Warrens A, Lechler RI. Clinical xenotransplantation of solid organs. Lancet 1997; 349(9055): 867-871.
2. Allan JS. Xenotransplantation and possible emerging infectious diseases. Mol Diagn 1996; 1(3): 209-217.
3. Allan JS. The risk of using baboons as transplant donors. Exogenous and endogenous viruses. Ann N Y Acad Sci 1998; 862: 87-99.
4. Cooper DK, Gollackner B, Knosalla C, Teranishi K. Xenotransplantation-how far have we come? Transpl Immunol 2002; 9(2-4): 251-256.
5. Samstein B, Platt JL. Physiologic and immunologic hurdles to xenotransplantation. J Am Soc Nephrol 2001; 12(1): 182-193.
6. Patience C, Takeuchi Y, Weiss RA. Zoonosis in xenotransplantation. Curr Opin Immunol 1998; 10(5): 539-542.
7. Blusch JH, Patience C, Martin U. Pig endogenous retroviruses and xenotransplantation. Xenotransplantation 2002; 9(4): 242-251.
8. Tucker A, Belcher C, Moloo B, et al. The production of transgenic pigs for potential use in clinical xenotransplantation: microbiological evaluation. Xenotransplantation 2002; 9(3): 191-202.
9. Le Tissier P, Stoye JP, Takeuchi Y, et al. Two sets of human-tropic pig retrovirus. Nature 1997; 389(6652): 681-682.
10. Patience C, Takeuchi Y, Weiss RA. Infection of human cells by an endogenous retrovirus of pigs. Nat Med 1997; 3(3): 282-286.
11. van der Laan LJ, Lockey C, Griffeth BC, et al. Infection by porcine endogenous retrovirus after islet xenotransplantation in SCID mice. Nature 2000; 407(6800): 90-94.
12. Zhong R. Gal knockout and beyond. Am J Transplant 2007; 5(7): 5-11.
13. Takeuchi Y, Patience C, Magre S, et al. Host range and interference studies of three classes of pig endogenous retrovirus. J Virol 1998; 72(12): 9986-9991.
14. Patience C, Switzer WM, Takeuchi Y, et al. Multiple groups of novel retroviral genomes in pigs and related species. J Virol 2001; 75(6): 2771-2775.
15. Niebert M, Rogel-Gaillard C, Chardon P, Tönjes RR. Characterization of chromosomally assigned replication-competent gamma porcine endogenous retroviruses derived from a large white pig and expression in human cells. J Virol 2002; 76(6): 2714-2720.
16. Herring C, Quinn G, Bower R, et al. Mapping full-length porcine endogenous retroviruses in a large white pig. J Virol 2001; 75(24): 12252-12265.
17. Akiyoshi DE, Denaro M, Zhu H, et al. Identification of a full-length cDNA for an endogenous retrovirus of miniature swine. J Virol 1998; 72(5): 4503-4507.
18. Bosch S, Arnauld C, Jestin A. Study of full-length porcine endogenous retrovirus genomes with envelope gene polymorphism in a specific-pathogen-free Large White swine herd. J Virol 2000; 74(18): 8575-8581.
19. Martin J, Herriou E, Cook J, et al. Interclass transmission and phyletic host tracking in murine leukemia virus-related retroviruses. J Virol 1999; 73(3): 2442-2449.
20. Magre S, Takeuchi Y, Bartosch B. Xenotransplantation and pig endogenous retroviruses. Rev Med Virol 2003; 13(5): 311-329.
21. Martin U, Kiessig V, Blusch JH, et al. Expression of pig endogenous retrovirus by primary porcine endothelial cells and infection of human cells. Lancet 1998; 352(9129): 692-694.
22. Langford GA, Galbraith D, Whittam AJ, et al. In vivo analysis of porcine endogenous retrovirus expression in transgenic pigs. Transplantation 2001; 72(12): 1996-2000.
23. Takefman DM, Wong S, Maudru T, et al. Detection and characterization of porcine endogenous retrovirus in porcine plasma and porcine factor VIII. J Virol 2001. 75(10): 4551-4557.
24. Tacke SJ, Specke V, Denner J. Differences in release and determination of subtype of porcine endogenous retroviruses produced by stimulated normal pig blood cells. Intervirology 2003; 46(1): 17-24.
25. Wilson CA, Wong S, Muller J, et al. Type C retrovirus released from porcine primary peripheral blood mononuclear cells infects human cells. J Virol 1998; 72(4): 3082-3087.
26. Wilson CA, Wong S, VanBrocklin M, Federspiel MJ. Extended analysis of the in vitro tropism of porcine endogenous retrovirus. J Virol 2000; 74(1): 49-56.
27. Blusch JH, Patience C, Takeuchi Y, et al. Infection of nonhuman primate cells by pig endogenous retrovirus. J Virol 2000; 74(16): 7687-7690.
28. Martin U, Winkler ME, Id M, et al. Productive infection of primary human endothelial cells by pig endogenous retrovirus (PERV). Xenotransplantation 2000; 7(2): 138-142.
29. Specke V, Tacke SJ, Boller K, et al. Porcine endogenous retroviruses: in vitro host range and attempts to establish small animal models. J Gen Virol 2001; 82(Pt 4): 837-844.
30. Krach U, Fischer N, Czauderna F, Tönjes RR. Comparison of replication-competent molecular clones of porcine endogenous retrovirus class A and class B derived from pig and human cells. J Virol 2001; 75(12): 5465-5472.
31. Onions D, Cooper DK, Alexander TJ, et al. An approach to the control of disease transmission in pig-to-human xenotransplantation. Xenotransplantation 2000; 7(2): 143-155.
32. Oldmixon BA, Wood JC, Ericsson TA, et al. Porcine endogenous retrovirus transmission characteristics of an inbred herd of miniature swine. J Virol 2002; 76(6): 3045-3048.
33. Martin SI, Wilkinson R, Fishman JA. Genomic presence of recombinant porcine endogenous retrovirus in transmitting miniature swine. Virol J 2006; 3: 91.
34. Wood JC, Quinn G, Suling KM, et al. Identification of exogenous forms of human-tropic porcine endogenous retrovirus in miniature Swine. J Virol 2004; 78(5): 2494-2501.
35. Ericsson TA, Takeuchi Y, Templin C, et al. Identification of receptors for pig endogenous retrovirus. Proc Natl Acad Sci USA 2003; 100(11): 6759-6764.
36. Watanabe R, Miyazawa T, Matsuura Y. Cell-binding properties of the envelope proteins of porcine endogenous retroviruses. Microbes Infect 2005; 7(4): 658-665.
37. Lavillette D, Kabat D. Porcine endogenous retroviruses infect cells lacking cognate receptors by an alternative pathway: implications for retrovirus evolution and xenotransplantation. J Virol 2004; 78(16): 8868-8877.
38. Tailor CS, Lavillette D, Marin M, Kabat D. Cell surface receptors for gammaretroviruses. Curr Top Microbiol Immunol 2003; 281: 29-106.
39. Baranowski E, Ruiz-Jarabo CM, Domingo E. Evolution of cell recognition by viruses. Science 2001; 292(5519): 1102-1105.
40. Barnett AL, Wensel DL, Li W, et al. Structure and mechanism of a coreceptor for infection by a pathogenic feline retrovirus. J Virol 2003; 77(4): 2717-2729.
41. Wensel DL, Li W, Cunningham JM, A virus-virus interaction circumvents the virus receptor requirement for infection by pathogenic retroviruses. J Virol 2003; 77(6): 3460-3469.
42. Klymiuk N, Müller M, Brem G, Aigner B. Characterization of porcine endogenous retrovirus gamma pro-pol nucleotide sequences. J Virol 2002; 76(22): 11738-11743.
43. Lieber MM, Sherr CJ, Todaro GJ, et al. Isolation from the asian mouse Mus caroli of an endogenous type C virus related to infectious primate type C viruses. Proc Natl Acad Sci USA 1975; 72(6): 2315-2319.
44. Benveniste RE, Sherr CJ, Todaro GJ, et al. Evolution of type C viral genes:origin of feline leukemia virus. Science 1975; 190(4217): 886-888.
45. Denner J, Specke V, Schwendemann J, Tacke SJ. Porcine endogenous retroviruses (PERVs): adaptation to human cells and attempts to infect small animals and non-human primates. Ann Transplant 2001; 6(3): 25-33.
46. Denner J, Specke V, Thiesen U, et al. Genetic alterations of the long terminal repeat of an ecotropic porcine endogenous retrovirus during passage in human cells. Virology 2003; 314(1): 125-133.
47. Scheef G, Fischer N, Krach U, Tönjes RR. The number of a U3 repeat box acting as an enhancer in long terminal repeats of polytropic replication-competent porcine endogenous retroviruses dynamically fluctuates during serial virus passages in human cells. J Virol 2001; 75(15): 6933-6940.
48. Athas GB, Lobelle-Rich P, Levy LS. Function of a unique sequence motif in the long terminal repeat of feline leukemia virus isolated from an unusual set of naturally occurring tumors. J Virol 1995; 69(6): 3324-3332.
49. Yoshimura FK, Wang T, Cankovic M. Sequences between the enhancer and promoter in the long terminal repeat affect murine leukemia virus pathogenicity and replication in the thymus. J Virol 1999; 73(6): 4890-4898.
50. Tacke S, Specke V, Stephen O, et al. Porcine endogenous retroviruses: diagnostic assays and evidence for immunosuppressive properties. Transplant Proc 2000; 32(5): 1166.
51. Tacke SJ, Kurth R, Denner J. Porcine endogenous retroviruses inhibit human immune cell function: risk for xenotransplantation? Virology 2000; 268(1): 87-93.
52. Suling K, Quinn G, Wood J, Patience C. Packaging of human endogenous retrovirus sequences is undetectable in porcine endogenous retrovirus particles produced from human cells. Virology 2003; 312(2): 330-336.
53. Cascalho M, Platt JL. The immunological barrier to xenotransplantation. Immunity 2001; 14(4): 437-446.
54. Cooper DK, Dorling A, Pierson III RN, et al. α1,3- Galactosyltransferase gene-knockout pigs for xenotransplantation: where do we go from here? Transplantation 2007; 84(1): 1-7.
55. Yang Y-G, Sykes M. Xenotransplantation: current status and a perspective on the future. Nat Med 2007; 11(1): 32-34.
56. Logan JS. Prospects for xenotransplantation. Curr Opin Immunol 2000; 12(5): 563-568.
57. Galili U. The alpha-gal epitope and the anti-Gal antibody in xenotransplantation and in cancer immunotherapy. Immunol Cell Biol 2005; 83(6): 674-686.
58. Cozzi E, White DJ. The generation of transgenic pigs as potential organ donors for humans. Nat Med 1995; 1(9): 964-966.
59. Miyagawa S, Hirose H, Shirakura R, et al. The mechanism of discordant xenograft rejection. Transplant Proc 1989; 21(1 Pt 1): 520-521.
60. McCurry KR, Kooyman DL, Diamond LE, et al. Human complement regulatory proteins in transgenic animals regulate complement activation in xenoperfused organs. Transplant Proc 1995; 27(1): 317-318.
61. Chen RH, Naficy S, Logan JS, et al. Hearts from transgenic pigs constructed with CD59/DAF genomic clones demonstrate improved survival in primates. Xenotransplantation 1999; 6(3): 194-200.
62. McCurry KR, Diamond LE, Kooyman DL, et al. Human complement regulatory proteins expressed in transgenic swine protect swine xenografts from humoral injury. Transplant Proc 1996; 28(2): 758.
63. Cozzi E, Bhatti F, Schmoeckel M, et al. Long-term survival of nonhuman primates receiving life-supporting transgenic porcine kidney xenografts. Transplantation 2000; 70(1): 15-21.
64. Cozzi E, Vial C, Ostlie D, et al. Maintenance triple immunosuppression with cyclosporin A, mycophenolate sodium and steroids allows prolonged survival of primate recipients of hDAF porcine renal xenografts. Xenotransplantation 2003; 10(4): 300-310.
65. Vial CM, Ostlie DJ, Bhatti FN, et al. Life supporting function for over one month of a transgenic porcine heart in a baboon. J Heart Lung Transplant 2000; 19(2): 224-229.
66. Magre S, Takeuchi Y, Langford G, et al. Reduced sensitivity to human serum inactivation of enveloped viruses produced by pig cells transgenic for human CD55 or deficient for the galactosyl-alpha(1-3) galactosyl epitope. J Virol 2004; 78(11): 5812-5819.
67. Takefman DM, Spear GT, Saifuddin M, Wilson CA. Human CD59 incorporation into porcine endogenous retrovirus particles: implications for the use of transgenic pigs for xenotransplantation. J Virol 2002; 76(4): 1999-2002.
68. McKenzie IF, Osman N, Cohney S, et al. Strategies to overcome the anti-Gal alpha (1-3)Gal reaction in xenotransplantation. Transplant Proc 1996; 28(2): 537.
69. Sharma A, Okabe J, Birch P, et al. Reduction in the level of Gal(alpha1,3)Gal in transgenic mice and pigs by the expression of an alpha(1,2)fucosyltransferase. Proc Natl Acad Sci USA 1996; 93(14): 7190-7195.
70. Phelps CJ, Koike C, Vaught TD, et al. Production of alpha 1,3-galactosyltransferase-deficient pigs. Science 2003; 299(5605): 411-414.
71. Dai Y, Vaught TD, Boone J, et al. Targeted disruption of the alpha1,3-galactosyltransferase gene in cloned pigs. Nat Biotechnol 2002; 20(3): 251-255.
72. Lai L, Kolber-Simonds D, Park KW, et al. Production of alpha-1,3-galactosyltransferase knockout pigs by nuclear transfer cloning. Science 2002; 295(5557): 1089-1092.
73. Yamada K, Yazawa K, Shimizu A, et al. Marked prolongation of porcine renal xenograft survival in baboons through the use of alpha1,3-galactosyltransferase gene-knockout donors and the cotransplantation of vascularized thymic tissue. Nat Med 2005; 11(1): 32-34.
74. Tseng YL, Kuwaki K, Dor FJ, et al. alpha1,3-Galactosyltransferase gene-knockout pig heart transplantation in baboons with survival approaching 6 months. Transplantation 2005; 80(10): 493-500.
75. Kuwaki K, Tseng YL, Dor FJ, et al. Heart transplantation in baboons using alpha1,3-galactosyltransferase gene-knockout pigs as donors: initial experience. Nat Med 2005; 11(1): 9-31.
76. Quinn G, Wood JC, Ryan DJ, et al. Porcine endogenous retrovirus transmission characteristics of galactose alpha1-3 galactose-deficient pig cells. J Virol 2004; 78(11): 5805-5811.
77. Breimer ME. Seventh Congress of the International Xenotransplantation Association (IXA), Glasgow, 2003: "in vitro" highlights. Xenotransplantation 2004; 11(3): 226-227.
78. Clark KJ, Carlson DF, Foster LK, et al. Enzymatic engineering of the porcine genome with transposons and recombinases. BMC Biotechnol 2007; 17(7): 42.
79. Goff SP. In Fields Virology. Knipe DM, Howley PM, et al. Fourth Edition Lippincot Williams & Wilkins, 2001 [Field's online edition].
80. Dieckhoff B, Karlas A, Hofmann A, et al. Inhibition of porcine endogenous retroviruses (PERVs) in primary porcine cells by RNA interference using lentiviral vectors. Arch Virol 2007; 152(3): 629-634.
81. Karlas A, Kurth R, Denner J, Inhibition of porcine endogenous retroviruses by RNA interference: increasing the safety of xenotransplantation. Virology 2004; 325(1): 8-23.
82. Griffiths PD. Xenotransplantation: one trotter forward, one claw back. Lancet 2000; 356(9235): 1049-1050.
83. Lauret E, Riviere I, Rousseau V, et al. Development of methods for somatic cell gene therapy directed against viral diseases, using retroviral vectors carrying the murine or human interferon-beta coding sequence: establishment of the antiviral state in human cells. Hum Gene Ther 1993; 4(5): 567-577.
84. Qari SH, Magre S, García-Lerma JG, et al. Susceptibility of the porcine endogenous retrovirus to reverse transcriptase and protease inhibitors. J Virol 2001; 75(2): 1048-1053.
85. Heneine W, Tibell A, Switzer WM, et al. No evidence of infection with porcine endogenous retrovirus in recipients of porcine islet-cell xenografts. Lancet 1998; 352(9129): 695-699.
86. Patience C, Patton GS, Takeuchi Y, et al. No evidence of pig DNA or retroviral infection in patients with short-term extracorporeal connection to pig kidneys. Lancet 1998; 352(9129): 699-701.
87. Paradis K, Langford G, Long Z, et al. Search for cross-species transmission of porcine endogenous retrovirus in patients treated with living pig tissue. The XEN 111 Study Group. Science 1999; 285(5431): 1236-1241.
88. Dinsmore JH, Manhart C, Raineri R, et al. No evidence for infection of human cells with porcine endogenous retrovirus (PERV) after exposure to porcine fetal neuronal cells. Transplantation 2000; 70(9): 1382-1389.
89. Tacke SJ, Bodusch K, Berg A, Denner J, et al. Sensitive and specific immunological detection methods for porcine endogenous retroviruses applicable to experimental and clinical xenotransplantation. Xenotransplantation 2001; 8(2): 125-135.
90. Denner J. Porcine endogenous retroviruses (PERVs) and xenotransplantation: screening for transmission in several clinical trials and in experimental models using non-human primates. Ann Transplant 2003; 8(3): 39-48.
91. Sauer IM, Kardassis D, Zeillinger K, et al. Clinical extracorporeal hybrid liver support-phase I study with primary porcine liver cells. Xenotransplantation 2003; 10(5): 460-169.
92. Irgang M, Sauer IM, Karlas A, et al. Porcine endogenous retroviruses: no infection in patients treated with a bioreactor based on porcine liver cells. J Clin Virol 2003; 28(2): 141-154.
93. Garkavenko O, Croxson MC, Irgang M, et al. Monitoring for presence of potentially xenotic viruses in recipients of pig islet xenotransplantation. J Clin Microbiol 2004; 42(11): 5353-5356.
94. Di Nicuolo G, van de Kerkhove MP, Hoekstra R, et al. No evidence of in vitro and in vivo porcine endogenous retrovirus infection after plasmapheresis through the AMC-bioartificial liver. Xenotransplantation 2005; 12(4): 286-292.
95. Deng YM, Tuch BE, Rawlinson WD. Transmission of porcine endogenous retroviruses in severe combined immunodeficient mice xenotransplanted with fetal porcine pancreatic cells. Transplantation 2000; 70(7): 1010-1016.
96. Clémenceau B, Jégou D, Martignat L, Saï P. Microchimerism and transmission of porcine endogenous retrovirus from a pig cell line or specific pathogen-free pig islets to mouse tissues and human cells during xenografts in nude mice. Diabetologia 2002; 45(6): 914-923.
97. Martina Y, Kurian S, Cherqui S, et al. Pseudotyping of porcine endogenous retrovirus by xenotropic murine leukemia virus in a pig islet xenotransplantation model. Am J Transplant 2005; 5(8): 1837-1847.
98. Yang YG, Wood JC, Lan P, et al. Mouse retrovirus mediates porcine endogenous retrovirus transmission into human cells in long-term human-porcine chimeric mice. J Clin Invest 2004; 114(5): 695-700.
99. Irgang M, Karlas A, Laue C, et al. Porcine endogenous retroviruses PERV-A and PERV-B infect neither mouse cells in vitro nor SCID mice in vivo. Intervirology 2005; 48(2-3): 167-173.
100. Argaw T, Colon-Moran W, Wilson CA. Limited infection without evidence of replication by porcine endogenous retrovirus in guinea pigs. J Gen Virol 2004; 85(Pt 1): 15-19.
101. Winkler ME, Winkler M, Burian R, et al. Analysis of pig-to-human porcine endogenous retrovirus transmission in a triple-species kidney xenotransplantation model. Transpl Int 2005; 17(12): 848-858.
102. Specke V, Plesker R, Coulibaly C, et al. Productive infection of a mink cell line with porcine endogenous retroviruses (PERVs) but lack of transmission to minks in vivo. Arch Virol 2002; 147(2): 305-319.
103. Martin U. Porcine endogenous retrovirus (PERV) was not transmitted from transplanted porcine endothelial cells to baboons in vivo. Transpl Int 1998; 11(4): 247-251.
104. Specke V, Schuurman HJ, Plesker R, et al. Virus safety in xenotransplantation: first exploratory in vivo studies in small laboratory animals and non-human primates. Transpl Immunol 2002; 9(2-4): 281-288.
105. Switzer WM, Michler RE, Shanmugam V, et al. Lack of cross-species transmission of porcine endogenous retrovirus infection to nonhuman primate recipients of porcine cells, tissues, or organs. Transplantation 2001; 71(7): 959-965.
106. Simon AR, Templin C, Schroder C, et al. No evidence for productive PERV infection of baboon cells in in vivo infection model. Ann Transplant 2003; 8(3): 24-34.
107. Moscoso I, Hermida-Prieto M, Manez R, et al. Lack of cross-species transmission of porcine endogenous retrovirus in pig-to-baboon xenotransplantation with sustained depletion of anti-alphagal antibodies. Transplantation 2005; 79(7): 777-782.
108. Nishitai R, Ikai I, Shiotani T, et al. Absence of PERV infection in baboons after transgenic porcine liver perfusion. J Surg Res 2005; 124(1): 45-51.
109. Ogle BM, Butters KA, Plummer TB, et al. Spontaneous fusion of cells between species yields transdifferentiation and retroviral transfer in vivo. Faseb J 2004; 18(3): 548-550.
110. Martina Y, Marcucci KT, Cherqui S, et al. Mice transgenic for a human porcine endogenous retrovirus receptor are susceptible to productive viral infection. J Virol 2006; 80(7): 3135-3146.